z-logo
open-access-imgOpen Access
Conservation of synteny between the genome of the pufferfish (Fugu rubripes) and the region on human chromosome 14 (14q24.3) associated with familial Alzheimer disease (AD3 locus)
Author(s) -
Michael K. Trower,
Sarah-Michelle Orton,
Ian J. Purvis,
Philippe Sanséau,
John Riley,
Chri Christodoulou,
Doreen Burt,
Chee Gee See,
Greg Elgar,
Robin Sherrington,
Evgeny I. Rogaev,
Peter St George-Hyslop,
Sydney Brenner,
Colin W. Dykes
Publication year - 1996
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.93.4.1366
Subject(s) - synteny , fugu , genome , biology , locus (genetics) , takifugu rubripes , genetics , gene , human genome , whole genome sequencing , human genetics , chromosome
The genome of the pufferfish (Fugu rubripes) (400 Mb) is approximately 7.5 times smaller than the human genome, but it has a similar gene repertoire to that of man. If regions of the two genomes exhibited conservation of gene order (i.e., were syntenic), it should be possible to reduce dramatically the effort required for identification of candidate genes in human disease loci by sequencing syntenic regions of the compact Fugu genome. We have demonstrated that three genes (dihydrolipoamide succinyltransferase, S31iii125, and S20i15), which are linked to FOS in the familial Alzheimer disease focus (AD3) on human chromosome 14, have homologues in the Fugu genome adjacent to Fugu cFOS. The relative gene order of cFOS, S31iii125, and S20i15 was the same in both genomes, but in Fugu these three genes lay within a 12.4-kb region, compared to >600 kb in the human AD3 locus. These results demonstrate the conservation of synteny between the genomes of Fugu and man and highlight the utility of this approach for sequence-based identification of genes in human disease loci.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here